Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,563 across all filing types
Latest filing 2018-08-21 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
第三届监事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Zhejiang Huatong Pharmaceutical Co., Ltd. It details the decisions made in the 12th meeting of the 3rd Supervisory Board, including approval of using raised funds to increase capital in a subsidiary and using temporarily idle raised funds for cash management. The document includes voting results and references to related announcements published elsewhere. The content is about board meeting resolutions and approvals, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive meeting decisions and voting results. The document fits best under Board/Management Information (MANG) as it relates to governance decisions and supervisory board resolutions.
2018-08-21 Chinese
独立董事关于第三届董事会第十五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the use of raised funds and cash management related to a board meeting held on August 21, 2018. It references compliance with laws and regulations concerning the use of raised funds and the company's articles of association. The document is a formal opinion on specific board matters rather than a full financial report, earnings release, or regulatory filing. It is related to board/management information about decisions and opinions on company fund usage. The document length is short (1066 characters), and it contains detailed independent director opinions on board meeting matters, which fits the category of Board/Management Information (MANG).
2018-08-21 Chinese
华金证券股份有限公司关于公司使用部分暂时闲置募集资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding the use of temporarily idle raised funds by Zhejiang Huatong Pharmaceutical Co., Ltd. for cash management. It includes background on the raised funds, intended use, risk analysis, control measures, and approvals by the board and supervisory committee. The document references regulatory guidelines and approvals but does not contain financial statements or quarterly/yearly financial results. It is a formal verification or audit opinion related to the use of raised funds, which aligns with an Audit Report / Information filing rather than an announcement or a full annual/interim report. The document length is about 3,000 characters, which is consistent with a standalone audit or verification report rather than a full annual or interim report. Therefore, the most appropriate classification is AR (Audit Report / Information). Q3 2018
2018-08-21 Chinese
华金证券股份有限公司关于公司使用募集资金向全资子公司增资实施募投项目的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from a sponsoring institution (华金证券股份有限公司) regarding the use of raised funds by 浙江华通医药股份有限公司 to increase capital in its wholly-owned subsidiary for project implementation. It references regulatory approvals, fundraising details, board meeting approvals, and compliance with relevant securities regulations. The document is focused on the verification and compliance of the use of raised funds rather than the financial statements or audit results themselves. It is not an annual report, audit report, or earnings release. It is also not a simple announcement of a report publication. The document is a formal verification opinion related to capital use and compliance, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories and is a regulatory compliance document.
2018-08-21 Chinese
第三届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 15th meeting of the third board of directors of Zhejiang Huatong Pharmaceutical Co., Ltd. It details decisions made regarding capital increases, opening of special accounts for raised funds, cash management of idle funds, and the scheduling of an extraordinary general meeting. The content focuses on board meeting decisions and procedural matters rather than full financial statements or detailed financial performance. The document length is relatively short (2346 characters) and it is an announcement of board resolutions, not a full report or financial statement. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2018-08-21 Chinese
关于召开2018年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2018 first extraordinary general meeting (临时股东大会) of Zhejiang Huatong Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures (including online voting), registration details, agenda items, and proxy forms. There is no financial data or report content, but rather a formal announcement and instructions for shareholders to participate in the meeting and vote on proposals. This matches the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document is not an actual report (like Annual Report or Interim Report), nor is it a voting result announcement or a simple meeting notice. It is a comprehensive proxy solicitation document for the shareholders' meeting.
2018-08-21 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.